Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in Kayseri, Turkey  by Esel, D. et al.
ORIGINAL ARTICLE
Epidemiology of penicillin resistance in Streptococcus pneumoniae
isolates in Kayseri,Turkey
D. Esel1, B. Su¨merkan1 and S. Kocago¨z2
1Department of Microbiology, University of Erciyes, Kayseri, Turkey and 2Department of Infectious Diseases, University
of Hacettepe, Ankara, Turkey
Objective To determine the penicillin resistance and serotype distribution of Streptococcus pneumoniae strains
and to identify clonal relationships of isolates resistant to penicillin by means of pulsed-field gel
electrophoresis (PFGE).
Methods In total, 193 S. pneumoniae strains were isolated from clinical specimens between November 1997
and January 2000. Susceptibility testing was carried out by E test, and serotyping by the Quellung reaction.
Clonal relationship was analyzed by using PFGE with smaI endonuclease.
Results Of the S. pneumoniae isolates, 23% were intermediately resistant to penicillin. There were no
high-level resistant pneumococci. The majority of isolates intermediately resistant to penicillin were
of serogroups/serotypes 19, 23, 14 and 1, in descending order of frequency. There were eight major clones in
strains intermediately resistant to penicillin. It was seen that serogroups in the 23-valent polysaccharide
vaccine, 7-valent, 9-valent, and 11-valent vaccine formulations caused 92%, 75%, 78% and 87% of
pneumococcal diseases in our region, respectively.
Conclusion Penicillin resistance in S. pneumoniae is relatively uncommon in Kayseri. All vaccine formulations
can prevent the majority of pneumococcal diseases, and there is genetic heterogeneity in intermediately
penicillin-resistant pneumococci in this region.
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INTRODUCTION
Streptococcus pneumoniae is the leading bacterial cause of com-
munity-acquired pneumonia as well as acute otitis media,
sinusitis, and meningitis. Despite the advent of penicillin and
effective antimicrobial agents, and the availability of vaccine,
pneumococcal infections are still associated with high morbidity
and mortality rates [1,2]. Since the first description of a strain
with diminished susceptibility in 1967, resistance among Strep-
tococcus pneumoniae isolates has rapidly spread throughout the
world [3,4].
Clonal spread and horizontal gene transfer are the plausible
explanations for the rapid emergence of penicillin-resistant
Streptococcus pneumoniae [5]. Clonal spread is the cause of spread
of resistant strains between different countries and continents
[6,7].
Prevention of pneumococcal disease with vaccine is very
important, particularly for individuals in high-risk groups,
to decrease morbidity and mortality. The currently available
pneumococcal polysaccharide vaccine is not protective in
children under 2 years old and in immunosuppressed patients
[8]. To improve the current pneumococcal polysaccharide
vaccines, new conjugate vaccines in which polysaccharides
are covalently linked to carrier proteins have been developed
[9].
It is very important to know the serotype distribution and
antibiotic resistance in a particular area in order to estimate the
probable efficacy of the vaccines in that region [10,11].
The aims of this study were to determine the serotype
distribution and penicillin resistance of Streptococcus pneumoniae
strains in Kayseri and to identify clonal relationships of peni-




The pneumococcal strains were isolated from 193 patients in the
Department of Microbiology of Erciyes University Hospital in
Kayseri, a city in central Turkey with a population of about
800 000. All of the isolates were collected from patients
with community-acquired infection. The study was performed
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over a period of 26 months (November 1997 to January 2000).
The strains were isolated from different specimen sources: 49
from sputum, 34 from cerebrospinal fluid, 33 from ear dis-
charge, 26 from blood infections, 22 from ocular samples, 10
from pleural fluid, eight from soft tissue, seven from nasotra-
cheal aspirate, two from bronchoalveolar lavage, and one from
peritoneal fluid.
Identification was carried out by colony morphology on
blood agar, Gram stain, susceptibility to optochin, and bile
solubility [12]. Strains were stored in microbanks at 70 8C
until analyzed.
Streptococcus pneumoniae ATCC 49619 was used as the quality
control strain for susceptibility testing, and Staphylococcus aureus
NCTC 8325 to ensure the comparability of the gels during
PFGE.
Sensitivity to penicillin G
Susceptibility testing was performed by E test (AB Biodisk,
Solna, Sweden) on Mueller–Hinton agar with 5% sheep blood
and incubation in the presence of 5% CO2. The E test was
performed according to the manufacturer’s instructions. Strains
with MIC 0.06 mg/L were considered to be susceptible,
those with MICs between 0.1 and 1.0 mg/L intermediate,
and those with MIC 2.0 mg/L highly resistant, according
to the NCCLS protocol [13].
Serotyping
Serotyping was performed by the Quellung reaction with
Pneumotest (Statens Serum Institute, Copenhagen, Denmark).
Pulsed-field gel electrophoresis
This part of the study was performed in Hacettepe University
Faculty of Medicine, Department of Infectious Diseases,
Ankara, Turkey. PFGE was carried out on intermediately
resistant isolates (n¼ 44). Streptococcus pneumoniae DNA em-
bedded in agarose blocks was prepared as described by Soares
[6]. For digestion, restriction endonuclease smaI (Promega,
Madison, WI, USA) was used. The DNA macrorestriction
fragments were separated in 1.1% agarose gel (Genaxis, Spech-
bach, Germany) by PFGE (General Navigator, Pharmacia,
Uppsala, Sweden). l-Ladder (Sigma, Deisenhofen, Germany)
was used as a molecular weight marker.
Analysis of PFGE profiles
Visual comparison of macrorestriction patterns of the chromo-
somal DNAs was done using the ‘Alpha Imager Documentation
and Analysis System’ (USA), and distinct patterns were assigned
an arbitrary PFGE designation. Assuming that a single muta-
tional event in the chromosomal DNA could introduce maxi-
mally a three-fragment difference in the restriction pattern,
strains showing more than three-fragment variations were
assumed to represent major patterns (assignment of capital
letters), while one- to three-fragment differences were con-
sidered to represent subtypes (capital letters with numerical
subcode) [14].
RESULTS
Intermediate-level penicillin resistance was observed in 44
(23%) of the 193 strains, while there was no strain highly
resistant to penicillin. MIC range, MIC50 and MIC90 (mg/L)
of the strains for penicillin were 0.004–1, 0.01, and 0.25,
respectively.
The serogroup/serotype distribution of 193 strains is shown
in Figure 1. Fifteen strains (8%) could not be serotyped with
Pneumotest. It was seen that the majority of isolates were of
Figure 1 Serogroup/serotype distribution of
193 Streptococcus pneumoniae strains.
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serogroups/serotypes 19, 1, 6, 23 and 3, in descending order of
frequency. Among the 44 intermediately resistant strains, the
most predominant serogroups/serotypes were found to be 19
(n¼ 22), 23 (n¼ 11), 14 (n¼ 3), and 1 (n¼ 3).
The clonal relationships of isolates that were intermediately
resistant to penicillin were analyzed by means of PFGE. In these
strains, eight major patterns (A–H) were observed. The major-
ity of the strains (41%) belonged to PFGE type A; however,
there were three different subtypes in clone A. Representative
patterns of the predominant PFGE types are shown in Figure 2.
No relationship was found between serotypes and PFGE
types. Genetic heterogeneity was seen in strains intermediately
resistant to penicillin.
DISCUSSION
Shortly after the isolation of pneumococci with moderate
penicillin resistance in Australia and New Guinea [15], peni-
cillin-resistant pneumococci emerged in many countries.
Today, the prevalence of pneumococci resistant to penicillin
is increasing worldwide, particularly in Spain [16,17], Hungary
[18], and South Africa [19]. Antimicrobial use is generally
considered to be one of the major factors in resistance
[20,21]. Although antimicrobial use is relatively unrestricted,
and self-administration is common in Kayseri, it is surprising
that there is still no highly resistant pneumococcal strain and no
increase in the prevalence of intermediate-level resistance from
1992 to 2000 in this region [22,23].
It is known that serotype distribution of strains causing
invasive disease, nasopharyngeal colonisation and antibiotic
resistance is related to age, geography, and socio-economic
conditions. Analysis of the leading serotypes in a particular area
is very important to evaluate the efficacy of vaccines [10,11].
Penicillin resistance is restricted worldwide to a few ser-
ogroups. These serogroups are 6, 9, 14, 19, and 23 [24–27].
However, there is a much wider range in serogroups of the
strains intermediately resistant to penicillin [28]. In this study,
we found that the leading serogroups/serotypes were 19, 1 and 6
in Kayseri. Intermediate-level resistance to penicillin was
mostly observed in serogroups 19 and 23. It was observed that
serogroups in the 23-valent-polysaccharide vaccine, 7-valent,
9-valent and 11-valent vaccine formulations caused 92%, 75%,
78% and 87% of pneumococcal diseases in Kayseri, respect-
ively. Each formulation can be used and prevent most of the
pneumococcal diseases in this region.
There are three hypotheses about the rapid spread of
penicillin resistance:
1. The altered penicillin-binding protein (PBP) genes arise by
interspecies recombinational events in which segments of
native PBP genes are replaced with the corresponding
segments from related streptococcal species [29,30].
2. Horizontal transfer of altered PBP genes from resistant
strains to susceptible strains is the main cause of spread of
resistance [31].
3. The importation and clonal spread of a small number of
resistant clones are important factors in the global increase in
the incidence of penicillin-resistant pneumococci [6,7].
In general, it can be proposed that resistant pneumococci that
are not closely related genetically but that contain identical
altered PBP genes have arisen by horizontal spread, whereas
Figure 2 Representative patterns of the
predominant PFGE types. M, molecular weight
marker (kb). Staphylococcus aureus NCTC
8325; Streptococcus pneumoniae ATCC
49619.
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isolates that are genetically indistinguishable are the result of
clonal spread [5]. Clonal spread is the most important mechan-
ism, and causes the spread of resistant clones to geographically
distinct areas [6,7].
Spanish serotype 23F strains [32] resistant to penicillin,
tetracycline, and chloramphenicol, and variably resistant to
erythromycin, have been described as a distinct clone that
has spread to numerous countries in Europe [6,31,33], the
USA [32,34], and South Africa [35]. The same bacterial clone,
but with a 19F capsule, has been found in many countries,
suggesting capsular switching [31,36,37]. Serotype 23F clones
unique to certain areas have been identified in Finland [38],
Italy [37], Israel [39], and Bulgaria [40]. Nevertheless, in Japan
and Korea, genetic heterogeneity has been reported in serotype
23F strains resistant to penicillin [41,42]. Not only the 23F
clone, but also the 14 [33,40], 9V [31,37] and 19A [18,40]
clones, have been dispersed throughout the world.
Although resistant strains have highly related PFGE patterns,
there is genetic heterogeneity in intermediate and susceptible
strains [38,43]. We found eight different major clones, of which
41% belonged to PFGE type A in our strains.
In conclusion, there are still no high-level penicillin-resistant
pneumococci in Kayseri. All of the vaccine formulations are
sufficient to prevent most of the pneumococcal diseases in this
region. There is no relationship between PFGE type and
serotype, and there is genetic heterogeneity in pneumococci
intermediately resistant to penicillin.
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